| Literature DB >> 29902444 |
Peng Zhang1, Jason Gorman2, Hui Geng2, Qingbo Liu1, Yin Lin1, Yaroslav Tsybovsky3, Eden P Go4, Barna Dey5, Tsion Andine1, Alice Kwon1, Mit Patel1, Deepali Gururani1, Ferzan Uddin1, Christina Guzzo1, Raffaello Cimbro1, Huiyi Miao1, Krisha McKee2, Gwo-Yu Chuang2, Loïc Martin6, Francesca Sironi7, Mauro S Malnati7, Heather Desaire4, Edward A Berger5, John R Mascola2, Michael A Dolan8, Peter D Kwong2, Paolo Lusso9.
Abstract
The HIV-1 envelope (Env) spike is a trimer of gp120/gp41 heterodimers that mediates viral entry. Binding to CD4 on the host cell membrane is the first essential step for infection but disrupts the native antigenic state of Env, posing a key obstacle to vaccine development. We locked the HIV-1 Env trimer in a pre-fusion configuration, resulting in impaired CD4 binding and enhanced binding to broadly neutralizing antibodies. This design was achieved via structure-guided introduction of neo-disulfide bonds bridging the gp120 inner and outer domains and was successfully applied to soluble trimers and native gp160 from different HIV-1 clades. Crystallization illustrated the structural basis for CD4-binding impairment. Immunization of rabbits with locked trimers from two different clades elicited neutralizing antibodies against tier-2 viruses with a repaired glycan shield regardless of treatment with a functional CD4 mimic. Thus, interdomain stabilization provides a widely applicable template for the design of Env-based HIV-1 vaccines. Published by Elsevier Inc.Entities:
Keywords: HIV-1; conformational changes; immunogenicity; neutralizing antibodies; pre-clinical models; protein stabilization; protein structure; receptor binding; vaccine; viral envelope
Mesh:
Substances:
Year: 2018 PMID: 29902444 PMCID: PMC6007033 DOI: 10.1016/j.chom.2018.05.002
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023